These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27603394)

  • 21. Prevalence of metabolic syndrome among elderly Mexicans.
    Ortiz-Rodríguez MA; Yáñez-Velasco L; Carnevale A; Romero-Hidalgo S; Bernal D; Aguilar-Salinas C; Rojas R; Villa A; Tur JA
    Arch Gerontol Geriatr; 2017 Nov; 73():288-293. PubMed ID: 28910752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemogram-based decision tree for predicting the metabolic syndrome and cardiovascular diseases in the elderly.
    Hsu CH; Chen YL; Hsieh CH; Liang YJ; Liu SH; Pei D
    QJM; 2021 Oct; 114(6):363-373. PubMed ID: 32573729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse effects of coexistence of sarcopenia and metabolic syndrome in Japanese women.
    Sanada K; Iemitsu M; Murakami H; Gando Y; Kawano H; Kawakami R; Tabata I; Miyachi M
    Eur J Clin Nutr; 2012 Oct; 66(10):1093-8. PubMed ID: 22569087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the impact of metabolic syndrome on cardiovascular events vary by using different definitions?
    Khosravi-Boroujeni H; Ahmed F; Sadeghi M; Roohafza H; Talaei M; Dianatkhah M; Pourmogaddas A; Sarrafzadegan N
    BMC Public Health; 2015 Dec; 15():1313. PubMed ID: 26715355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic Syndrome for Cardiovascular Disease Morbidity and Mortality Among General Japanese People: A Mini Review.
    Watanabe J; Kotani K
    Vasc Health Risk Manag; 2020; 16():149-155. PubMed ID: 32368073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
    Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
    PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity.
    van der Pouw Kraan TC; Chen WJ; Bunck MC; van Raalte DH; van der Zijl NJ; van Genugten RE; van Bloemendaal L; Baggen JM; Serné EH; Diamant M; Horrevoets AJ
    BMC Med Genomics; 2015 May; 8():20. PubMed ID: 25956355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of two metabolic syndrome definitions in the estimation of cardiovascular disease among hypertensive patients.
    Hirota AH; Rodrigues CJ; Borges RL; Ribeiro AB; Zanella MT; Batista MC
    J Clin Hypertens (Greenwich); 2010 Aug; 12(8):588-96. PubMed ID: 20695935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome components and prevalence of cardiovascular disease among type 2 diabetic patients in Malaysia.
    Tan MC; Wong TW; Ng OC; Joseph A; Hejar AR
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):226-35. PubMed ID: 24964674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?
    van der Velde M; Bello AK; Brantsma AH; El Nahas M; Bakker SJ; de Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2012 Jun; 27(6):2275-83. PubMed ID: 22231032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver and cardiovascular disease outcomes in metabolic syndrome and diabetic populations: Bi-directional opportunities to multiply preventive strategies.
    Yasin A; Nguyen M; Sidhu A; Majety P; Spitz J; Asgharpour A; Siddiqui MS; Sperling LS; Quyyumi AA; Mehta A
    Diabetes Res Clin Pract; 2024 May; 211():111650. PubMed ID: 38604447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.
    Ding C; Yang Z; Wang S; Sun F; Zhan S
    Endocrine; 2018 May; 60(2):282-291. PubMed ID: 29492904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex.
    Matsubayashi Y; Fujihara K; Yamada-Harada M; Mitsuma Y; Sato T; Yaguchi Y; Osawa T; Yamamoto M; Kitazawa M; Yamada T; Kodama S; Sone H
    Cardiovasc Diabetol; 2022 Jun; 21(1):90. PubMed ID: 35655263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study.
    Vishnu A; Gurka MJ; DeBoer MD
    Atherosclerosis; 2015 Nov; 243(1):278-85. PubMed ID: 26409627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A diagnosis of the metabolic syndrome in youth that resolves by adult life is associated with a normalization of high carotid intima-media thickness and type 2 diabetes mellitus risk: the Bogalusa heart and cardiovascular risk in young Finns studies.
    Magnussen CG; Koskinen J; Juonala M; Chen W; Srinivasan SR; Sabin MA; Thomson R; Schmidt MD; Nguyen QM; Xu JH; Skilton MR; Kähönen M; Laitinen T; Taittonen L; Lehtimäki T; Rönnemaa T; Viikari JS; Berenson GS; Raitakari OT
    J Am Coll Cardiol; 2012 Oct; 60(17):1631-9. PubMed ID: 23021330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic disorders increase the risk to incident cardiovascular disease in middle-aged and elderly Chinese.
    Zhang ML; Hou XH; Zhu YX; Lu JX; Peng LP; Gu HL; Jia WP
    Biomed Environ Sci; 2012 Feb; 25(1):38-45. PubMed ID: 22424625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normal fasting plasma glucose predicts type 2 diabetes and cardiovascular disease in elderly population in Taiwan.
    Huang CL; Chang HW; Chang JB; Chen JH; Lin JD; Wu CZ; Pei D; Hung YJ; Lee CH; Chen YL; Hsieh CH
    QJM; 2016 Aug; 109(8):515-22. PubMed ID: 26576838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus.
    Wilson PW; D'Agostino RB; Parise H; Sullivan L; Meigs JB
    Circulation; 2005 Nov; 112(20):3066-72. PubMed ID: 16275870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
    Ramezankhani A; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of anthropometric indices for predicting the risk of metabolic syndrome and its components in Chinese adults: a prospective, longitudinal study.
    Wang H; Liu A; Zhao T; Gong X; Pang T; Zhou Y; Xiao Y; Yan Y; Fan C; Teng W; Lai Y; Shan Z
    BMJ Open; 2017 Sep; 7(9):e016062. PubMed ID: 28928179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.